Article By:
ChinaBio® Today
Saturday, March 5, 2022 1:30 PM EDT
Adagene will apply its technology to as many as four Sanofi candidates in a collaboration worth up to $2.5 billion. Huadong Medicine will acquire Asia rights for two Heidelberg Pharma ADC candidates in a deal potentially worth more than $1 billion.